Liarozole
 | |
| Names | |
|---|---|
| IUPAC name
6-[(3-Chlorophenyl)-imidazol-1-ylmethyl]-1H-benzimidazole | |
| Identifiers | |
| 115575-11-6 | |
| 3D model (Jmol) | Interactive image |
| ChemSpider | 54664 |
| 5210 | |
| PubChem | 60652 |
| |
| |
| Properties | |
| C17H13ClN4 | |
| Molar mass | 308.77 g·mol−1 |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| Infobox references | |
Liarozole is a retinoic acid metabolism-inhibiting chemical.[1]
Synthesis
Liarozole synthesis from Lednicer book 6 (Drugs of the Future citation).
References
- ↑ Vahlquist, A; Blockhuys, S; Steijlen, P; Van Rossem, K; Didona, B; Blanco, D; Traupe, H (2013). "Oral liarozole in the treatment of patients with moderate/severe lamellar ichthyosis: Results of a randomized, double-blind, multinational, placebo-controlled phase II/III trial". The British journal of dermatology. 170 (1): n/a. doi:10.1111/bjd.12626. PMID 24102348.
This article is issued from Wikipedia - version of the 6/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.